β‘ Flash Summary
On October 31, 2025, First UDL Modaraba Staff Provident Fund, an associated company, sold 50,706 shares of UDL International Limited at a rate of PKR 19.86 per share. The transaction was executed on the ‘Ready’ market for CDC (Central Depository Company) share certificates. Following this transaction, the cumulative shareholding of First UDL Modaraba Staff Provident Fund stands at 117,000 shares, representing 0.33% of the company. This disclosure indicates a potential shift in the holdings of associated entities, which could influence investor sentiment.
π Key Takeaways
- π UDL International Limited disclosed a sale of shares by an associated company.
- π’ The associated company involved is First UDL Modaraba Staff Provident Fund.
- π 50,706 shares were sold by the associated company.
- π The transaction took place on October 31, 2025.
- πΉ The shares were sold at a rate of PKR 19.86 per share.
- π The transaction was executed in the ‘Ready’ market for CDC share certificates.
- π Following the sale, the cumulative shareholding is 117,000 shares.
- πΌ The cumulative shareholding represents 0.33% of the company.
- π The disclosure is related to a transaction executed by an associated company.
- π’ The transaction will be presented in the subsequent board meeting.
- πΌ Muhammad Faisal Siddiqui, Company Secretary, signed the disclosure.
- π The company’s head office is located in Karachi.
- π The company’s website is www.udl.com.pk.
- π§ The company’s email address is info@udl.com.pk.
π― Investment Thesis
Given the sale of a small portion of shares by an associated company, a HOLD recommendation is appropriate for UDL International Limited. The transaction does not fundamentally alter the company’s financials or long-term prospects, but it warrants monitoring for any further actions by associated entities. The current market conditions and sector dynamics should also be considered. Price Target: Maintain existing target. Time Horizon: Medium Term
Disclaimer: AI-generated analysis. Not financial advice.